Canaccord lowered the firm’s price target on ZoomInfo to $26 from $32 and keeps a Buy rating on the shares. The firm noted the cokpany posted another misstep as they await for a bottom in renewal cohorts and they say at these levels, the shares are too cheap to downgrade and they don’t see a lot of downside risk form here.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ZI: